GGEYX
Price
$26.39
Change
-$0.64 (-2.37%)
Updated
Mar 3 closing price
Net Assets
1.66B
VIGIX
Price
$203.79
Change
-$5.05 (-2.42%)
Updated
Mar 3 closing price
Net Assets
292.14B
Ad is loading...

GGEYX vs VIGIX

Header iconGGEYX vs VIGIX Comparison
Open Charts GGEYX vs VIGIXBanner chart's image
GuideStone Funds Growth Equity Instl
Price$26.39
Change-$0.64 (-2.37%)
VolumeN/A
Net Assets1.66B
Vanguard Growth Index Institutional
Price$203.79
Change-$5.05 (-2.42%)
VolumeN/A
Net Assets292.14B
GGEYX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GGEYX vs. VIGIX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGEYX is a Hold and VIGIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 292B vs. GGEYX (1.66B). VIGIX pays higher dividends than GGEYX: VIGIX (0.53) vs GGEYX (0.04). GGEYX was incepted earlier than VIGIX: GGEYX (24 years) vs VIGIX (27 years). GGEYX is a more actively managed with annual turnover of: 41.00 vs. VIGIX (5.00). GGEYX has a lower initial minimum investment than VIGIX: GGEYX (1000000) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 18.13 vs. GGEYX (1.31). VIGIX return over 5 years is better than : 118.14 vs. GGEYX (2.14).
GGEYXVIGIXGGEYX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years27 years-
Gain YTD-1.278-1.131113%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B292B1%
Annual Yield % from dividends0.040.538%
Returns for 1 year1.3118.137%
Returns for 3 years11.0651.0822%
Returns for 5 years2.14118.142%
Returns for 10 years2.22277.721%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HWBK31.260.52
+1.69%
Hawthorn Bancshares
CVAC3.08-0.02
-0.65%
CureVac NV
ENSC5.32-0.07
-1.30%
Ensysce Biosciences
FOLD9.15-0.35
-3.64%
Amicus Therapeutics
INCY70.35-3.15
-4.29%
Incyte Corp